Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
{{output}}
Background: In patients with active cancer and venous thromboembolism, whether extended treatment with a reduced dose of an oral anticoagulant is effective in preventing recurrent thromboembolic events and decreasing bleeding is ... ...
